JPRN-UMIN000029590已完成未知
An accompanying research for the Phase II study of nivolumab + bevacizumab + paclitaxel in patients with HER2-negative metastatic breast cancer:WJOG9917B(WJOG9917BTR) - Accompanying research for the Phase II breast cancer study WJOG9917B(WJOG9917BTR)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A study to investigate what effects FX125L (taken by mouth) has on adults with chronic inflammatory diseasesEUCTR2011-005036-26-GBFunxional Therapeutics Ltd
进行中（未招募）
不适用
A study to investigate what effects FX125L (taken by mouth) has on adults with mild to moderate asthmaAsthmaEUCTR2014-002052-84-GBSTX Pharma
已完成
2 期
An exploratory phase 2 study to asses the effect of Dapagliflozin on Glomerular Filtration Rate (GFR) in subjects with type 2 Diabetes who have inadequate glycemic and blood pressure (BP) control.Diabetes Mellitus Type 210018424NL-OMON33243Bristol-Myers Squibb15
已完成
1 期
CytoMegaloVirus: Alternate donor Study of Pre-Emptive Cellular TherapyISRCTN75391842Cell Medica Ltd (UK)18
进行中（未招募）
1 期
A prospective phase I/II study to investigate the feasibility, safety and efficacy of IL-15 activated cytokine induced killer (CIK) cells in relapsing patients with acute leukemia or myelodysplastic syndromes after allogeneic stem cell transplantatiorelapsing acute leukemia, relapsing myelodysplastic syndromesMedDRA version: 17.0Level: LLTClassification code 10000835Term: Acute leukemiaSystem Organ Class: 100000004864MedDRA version: 17.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-005446-11-DEGoethe-University Frankfurt40